Suppr超能文献

WS-23 在 Sprague-Dawley 大鼠急性及亚急性吸入毒性评价。

Acute and subacute inhalation toxicity assessment of WS-23 in Sprague-Dawley rats.

机构信息

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China.

Drug Evaluation Center, Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd., Guangzhou, China.

出版信息

J Appl Toxicol. 2021 Nov;41(11):1826-1838. doi: 10.1002/jat.4166. Epub 2021 Mar 23.

Abstract

2-isopropyl-N,2,3-trimethylbutyramide (WS-23) is a well-known artificial synthesis cooling agent widely used in foods, medicines, and tobaccos. As a commonly cooling agent in e-cigarette liquids, WS-23 has led to concerns about the inhalation toxicity with the prosperous of e-cigarettes in recent years. Thus, the aim of this study is to assess the acute and subacute inhalation toxicity of WS-23 in Sprague-Dawley (SD) rats according to the Organization for Economic Cooperation and Development (OECD) guidelines. In the acute toxicity study, there was no mortality and behavioral signs of toxicity at the limit test dose level (340.0 mg/m ) in the exposure period and the following 14-day observation period. In the subacute inhalation toxicity study, there was no significant difference observed in the body weights, feed consumption, and relative organ weights. Haematological, serum biochemical, urine, and bronchoalveolar lavage fluid (BALF) analysis revealed the non-adverse effects after 28-day repeated WS-23 inhalation (342.85 mg/m ), accompanied by slight changes in few parameters which returned to normal during the 28-day recovery period. The histopathologic examination also did not show any differences in vital organs. In conclusion, the maximum tolerated dose for WS-23 acute inhalation is not less than 340.0 mg/m , and the No Observed Adverse Effect Level (NOAEL) of WS-23 subacute inhalation was determined to be over 342.85 mg/m .

摘要

2-异丙基-N,2,3-三甲基丁酰胺(WS-23)是一种广为人知的人工合成冷却剂,广泛应用于食品、药品和烟草中。作为电子烟液体中的常用冷却剂,随着电子烟的普及,近年来人们对其吸入毒性产生了担忧。因此,本研究旨在根据经济合作与发展组织(OECD)的指导方针,评估 WS-23 对 Sprague-Dawley(SD)大鼠的急性和亚急性吸入毒性。在急性毒性研究中,在暴露期和随后的 14 天观察期内,最高测试剂量水平(340.0mg/m )下无死亡率和毒性行为迹象。在亚急性吸入毒性研究中,体重、饲料消耗和相对器官重量均无显著差异。血液学、血清生化、尿液和支气管肺泡灌洗液(BALF)分析表明,在 28 天重复 WS-23 吸入(342.85mg/m )后没有不良影响,少数参数略有变化,但在 28 天恢复期内恢复正常。组织病理学检查也未显示重要器官有任何差异。总之,WS-23 急性吸入的最大耐受剂量不低于 340.0mg/m ,WS-23 亚急性吸入的无观察不良效应水平(NOAEL)确定为 342.85mg/m 以上。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验